$885 Million is the total value of Rubric Capital Management LP's 48 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 130.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DD | New | DUPONT DE NEMOURS INC | $45,261,000 | – | 705,000 | +100.0% | 5.12% | – |
| MO | New | ALTRIA GROUP INC | $44,669,000 | – | 895,000 | +100.0% | 5.05% | – |
| DELL | Buy | DELL TECHNOLOGIES INCcl c | $43,682,000 | +20.3% | 850,000 | +21.4% | 4.94% | +48.3% |
| BGCP | Buy | BGC PARTNERS INCcl a | $40,956,000 | +12.4% | 6,894,866 | +4.1% | 4.63% | +38.6% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $38,280,000 | -7.3% | 2,126,080 | +4.3% | 4.33% | +14.3% |
| AVYA | New | AVAYA HLDGS CORP | $37,744,000 | – | 2,795,818 | +100.0% | 4.27% | – |
| STML | Buy | STEMLINE THERAPEUTICS INC | $37,205,000 | +38.4% | 3,500,000 | +35.5% | 4.20% | +70.6% |
| GPRE | Buy | GREEN PLAINS INC | $36,029,000 | +51.1% | 2,335,000 | +3.8% | 4.07% | +86.3% |
| QNST | Buy | QUINSTREET INC | $35,386,000 | +39.2% | 2,311,310 | +14.5% | 4.00% | +71.7% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $34,272,000 | +171.0% | 800,000 | +149.7% | 3.87% | +234.0% |
| RDUS | Buy | RADIUS HEALTH INC | $28,224,000 | -18.3% | 1,400,000 | +4.3% | 3.19% | +0.7% |
| TXMD | Buy | THERAPEUTICSMD INC | $26,652,000 | +6.7% | 11,013,187 | +60.1% | 3.01% | +31.5% |
| CSTM | New | CONSTELLIUM SE | $23,173,000 | – | 1,729,310 | +100.0% | 2.62% | – |
| TSN | New | TYSON FOODS INCcl a | $16,387,000 | – | 180,000 | +100.0% | 1.85% | – |
| UEPS | Buy | NET 1 UEPS TECHNOLOGIES INC | $11,078,000 | +17.1% | 2,977,922 | +12.4% | 1.25% | +44.4% |
| CHNG | New | CHANGE HEALTHCARE INC | $10,495,000 | – | 640,300 | +100.0% | 1.19% | – |
| CCO | New | CLEAR CHANNEL OUTDOOR HLDGS | $9,081,000 | – | 3,175,132 | +100.0% | 1.03% | – |
| IPHA | New | INNATE PHARMA S Asponsored ads | $8,694,000 | – | 1,350,000 | +100.0% | 0.98% | – |
| SEB | Buy | SEABOARD CORP | $8,539,000 | +7.1% | 2,009 | +10.2% | 0.96% | +32.0% |
| BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $7,869,000 | – | 2,614,417 | +100.0% | 0.89% | – |
| IMMR | Buy | IMMERSION CORP | $7,267,000 | +33.0% | 978,070 | +36.9% | 0.82% | +63.9% |
| AMPY | Buy | AMPLIFY ENERGY CORP NEW | $5,757,000 | +55.3% | 870,921 | +44.9% | 0.65% | +91.5% |
| SAIC | New | SCIENCE APPLICATNS INTL CP N | $4,958,000 | – | 56,973 | +100.0% | 0.56% | – |
| ASRT | New | ASSERTIO THERAPEUTICS INC | $4,500,000 | – | 3,600,316 | +100.0% | 0.51% | – |
| TBPH | New | THERAVANCE BIOPHARMA INC | $4,489,000 | – | 173,400 | +100.0% | 0.51% | – |
| HIIQ | New | HEALTH INS INNOVATIONS INCcall | $3,858,000 | – | 200,000 | +100.0% | 0.44% | – |
| VG | New | VONAGE HLDGS CORP | $2,596,000 | – | 350,371 | +100.0% | 0.29% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $1,640,000 | – | 28,579 | +100.0% | 0.18% | – |
| SRNE | New | SORRENTO THERAPEUTICS INC | $1,513,000 | – | 447,610 | +100.0% | 0.17% | – |
| MDRIQ | New | MCDERMOTT INTL INCput | $582,000 | – | 860,300 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-10 |
| DFAN14A | 2024-05-08 |
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
| PRRN14A | 2024-04-02 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.